Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLWB.L Regulatory News (LWB)

  • There is currently no data for LWB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and Transaction Update

17 Mar 2020 07:00

RNS Number : 3651G
Low & Bonar PLC
17 March 2020
 

Low & Bonar PLC

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF ANY SUCH JURISDICTION

FOR IMMEDIATE RELEASE

 

17 March 2020

Low & Bonar PLC

Trading and transaction update

Low & Bonar PLC ("Low & Bonar" or the "Group"), the international performance materials group, today issues updates on the Group's trading for the three months to 29 February 2020 and on the previously announced, and shareholder-approved, proposed acquisition of the Group by FV-Beteiligungs-GmbH ("Freudenberg") (the "Acquisition").

Trading and financial position

Further to the year-end update of 14 January 2020, conditions affecting the Group's end markets have remained challenging during the first quarter of the Group's 2020 financial year. In addition, the outbreak of the COVID-19 virus caused significant temporary disruption to the Group's Chinese operations in the last month of the quarter, with an extended shut down after the Chinese New Year holiday of both Chinese manufacturing facilities, and a pronounced slowdown in demand from local customers. We are pleased to report that both facilities can now operate at close to normal capacity. Subject to there being no extended disruption to supply chains, we would expect performance in our China business to pick up through the year. Sales in the APAC region, most of which are in China, account for approximately 10% of total Group revenues. We are very mindful that the further spread of the COVID-19 virus now being seen may have an effect on demand levels in our other markets, and as such could adversely affect trading across the rest of the Group. The potential impact of this is, inevitably, hard to predict at this point. The health and safety of our employees will, as always, remain of paramount importance.

Given the ongoing challenging market backdrop the Group continues to monitor its financial position closely, and to maintain a regular dialogue with its lenders. As announced on 10 October 2019, agreement was reached with Low & Bonar's lenders to amend the terms of the Group's financing facilities to assist the Company in progressing the Acquisition. As part of these amendments the testing of financial covenants as at 30 November 2019 was waived. Under the current amendments, and as set out on 10 October 2019, should the Acquisition lapse covenants would be reinstated and tested within 14 days with respect to the financial position as at the month-end previous to such lapse. In the event that the Acquisition does not complete by 30 June 2020, the scheduled covenant test as at 31 May 2020 would occur. Shareholders should note that, should the financial covenants be tested in line with the current amendments described above, it is very unlikely that the Group would be able to comply.

Acquisition update

As announced on 5 November 2019, the Acquisition has been approved by the Group's shareholders. Competition approval from the European Commission ("EC") in Phase 1 remains the key outstanding condition to the completion of the Acquisition. On 10 March 2020 the formal application for approval was submitted to the EC by Freudenberg, following several months of pre-notification information gathering by the respective parties, in dialogue with the EC, as is normal in such processes.

According to the EC's own guidelines, a formal decision on the Phase 1 review should be provided by 17 April 2020. The EC will provide feedback to the parties on its preliminary assessment of the application ahead of that date, which may include a preliminary view as to the likelihood of Phase 1 clearance. It should be noted that there can be no certainty at this stage as to the outcome of the Phase 1 review process. The Group will provide further updates as appropriate.

 

For further information, please contact:

Low & Bonar PLC

Daniel Dayan

Executive Chairman

020 7535 3180 

Ian Ashton

Group CFO

Instinctif Partners

020 7457 2020

Matthew Smallwood

Rosie Driscoll

 

Further information

This announcement is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities of Low & Bonar in any jurisdiction in contravention of applicable law. The Acquisition will be made solely by means of the scheme circular (or any subsequent document by which the Acquisition is made), which contains the full terms and conditions of the Acquisition.

This announcement does not constitute a prospectus or a prospectus equivalent document.

This announcement has been prepared for the purposes of complying with English law, the rules of the London Stock Exchange, the Listing Rules and the City Code on Takeovers and Mergers and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdictions outside the United Kingdom.

Overseas jurisdictions

The release, publication or distribution of this announcement in or into or from jurisdictions other than the UK may be restricted by law and therefore any persons who are subject to the law of any jurisdiction other than the UK should inform themselves about, and observe, any applicable legal or regulatory requirements. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. This announcement and the scheme circular have been prepared for the purposes of complying with UK company law and the City Code and the information disclosed may not be the same as that which would have been disclosed if they had been prepared in accordance with the laws of other jurisdictions.

Unless otherwise determined by Freudenberg or required by the City Code, and permitted by applicable law and regulation, the Acquisition will not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction or any other jurisdiction where to do so would violate the laws of that jurisdiction and no person may vote in favour of the Acquisition by any use, means, instrumentality or form within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Accordingly, copies of this announcement and the scheme circular will not be and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction or any jurisdiction where to do so would violate the laws of that jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in, into or from such jurisdictions where to do so would violate the laws of that jurisdiction.

The availability of the Acquisition to Low & Bonar Shareholders who are not resident in the UK may be affected by the laws of the relevant jurisdictions in which they are resident. Persons who are not resident in the UK should inform themselves of, and observe, any applicable requirements.

Notice to US Low & Bonar Shareholders

The Acquisition is being made to acquire the securities of a Scottish company by means of a scheme of arrangement under the Companies Act and the laws of Scotland. A transaction effected by means of a scheme of arrangement is not subject to the tender offer rules under the US Exchange Act. Accordingly, the Scheme will be subject to disclosure requirements and practices applicable in the UK to schemes of arrangement, which are different from the disclosure requirements of the US tender offer rules. The financial information included in the scheme circular has been prepared in accordance with accounting standards applicable in the UK and thus may not be comparable to financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the US.

It may be difficult for US holders of Low & Bonar Shares to enforce their rights and claims arising out of the US federal securities laws, since Freudenberg and Low & Bonar are located in countries other than the US, and some or all of their officers and directors may be residents of countries other than the US. US holders of Low & Bonar Shares may not be able to sue a non-US company or its officers or directors in a non-US court for violations of US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement.

The receipt of cash pursuant to the Acquisition by a US holder as consideration for the transfer of its Low & Bonar Shares pursuant to the Scheme will likely be a taxable transaction for US federal income tax purposes and under applicable US state and local, as well as foreign and other, tax laws. Each Low & Bonar Shareholder is urged to consult his or her independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him or her.

In accordance with normal UK practice and pursuant to Rule 14e-5(b) of the US Exchange Act, Freudenberg or its nominees, or its brokers (acting as agents), may from time to time make certain purchases of, or arrangements to purchase, Low & Bonar Shares outside of the US, other than pursuant to the Acquisition, until the date on which the Acquisition and/or Scheme becomes effective, lapses or is otherwise withdrawn. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. Any information about such purchases will be disclosed as required in the UK, will be reported to the Regulatory News Service of the London Stock Exchange and will be available on the London Stock Exchange website at http://www.londonstockexchange.com/prices-and-news/prices-news/home.htm.

Forward looking statements

This announcement, the scheme circular (including information incorporated by reference in the scheme circular), oral statements made regarding the Acquisition, and other information published by Freudenberg and Low & Bonar contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Freudenberg and Low & Bonar about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. The forward-looking statements contained in the scheme circular include statements relating to the expected effects of the Acquisition on Freudenberg and Low & Bonar, the expected timing and scope of the Acquisition and other statements other than historical facts. All statements other than statements of historical facts included in the scheme circular may be forward-looking statements. Without limitation, any statement preceded or followed by or that include the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "should", "could", "would", "may", "anticipates", "estimates", "synergy", "cost-saving", "projects", "goal", "strategy", "budget", "forecast" or "might" or, words or terms of similar substance or the negative thereof, are forward-looking statements. Forward-looking statements include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; (ii) business and management strategies and the expansion and growth of Freudenberg's or Low & Bonar's operations and potential synergies resulting from the Acquisition; and (iii) the effects of government regulation on Freudenberg's or Low & Bonar's business.

These forward-looking statements are not guarantees of future financial performance. Except as expressly provided in the scheme circular, they have not been reviewed by the auditors of Freudenberg or Low & Bonar or their respective financial advisers. Such forward-looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward-looking statements. These factors include the satisfaction of the Conditions, as well as additional factors, such as: fluctuations in the capital markets; fluctuations in interest and exchange rates; the occurrence of unforeseen disasters or catastrophes; political or economic instability in principal markets; adverse outcomes in litigation; and general, local and global economic, political, business and market conditions. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. Such forward-looking statements should therefore be construed in the light of such factors. Neither Freudenberg nor Low & Bonar, nor any of their respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in the scheme circular will actually occur. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements. All subsequent oral or written forward-looking statements attributable to Freudenberg or Low & Bonar or any of their respective members, directors, officers or employees or any persons acting on their behalf are expressly qualified in their entirety by the cautionary statement above. Freudenberg and Low & Bonar disclaim any obligation to update or revise any forward-looking or other statements contained in the scheme circular other than in accordance with their legal and regulatory obligations.

Disclosure requirements of the Takeover Code (the Code)

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Publication on website and availability of hard copies

A copy of this announcement will be made available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, free of charge on Low & Bonar's website at www.lowandbonar.com. For the avoidance of doubt, the contents of that website is not incorporated into and does not form part of this announcement.

Low & Bonar Shareholders may request a hard copy of this announcement by contacting Low & Bonar on +44 (0)20 7535 3180.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVQLFFBXLEBBD
Date   Source Headline
12th May 202011:53 amRNSForm 8.3 - Low & Bonar PLC
12th May 202010:59 amRNSForm 8.3 - Low & Bonar PLC
12th May 202010:59 amRNSForm 8.3 - Low & Bonar PLC
12th May 202010:55 amRNSForm 8.3 - Low & Bonar PLC
12th May 20209:51 amRNSScheme of arrangement
11th May 20205:43 pmRNSForm 8.3 - Low & Bonar PLC
11th May 20204:02 pmEQS***Amendment*** Form 8.3 - Tibra Trading Europe Ltd & Tibra Trading PTY Ltd: Low & Bonar PLC
11th May 20203:53 pmEQSForm 8.3 - Tibra Trading Europe Ltd & Tibra Trading PTY Ltd: Low & Bonar PLC
11th May 20203:29 pmRNSHolding(s) in Company
11th May 20203:15 pmPRNForm 8.3 - Low & Bonar plc
11th May 20202:56 pmEQSForm 8.3 - Tibra Trading PTY Limited: Low & Bonar PLC
11th May 20202:56 pmEQSForm 8.3 - Tibra Trading Europe Limited: Low & Bonar PLC
11th May 202011:00 amRNSForm 8.5 (EPT/RI)
7th May 20205:57 pmRNSForm 8.3 - Low & Bonar PLC
7th May 20205:02 pmRNSForm 8.3 - Low & Bonar plc
7th May 20203:14 pmPRNForm 8.3 - Low & Bonar plc
7th May 20202:55 pmEQSForm 8.3 - Tibra Trading Europe Limited: Low & Bonar PLC
7th May 20202:30 pmRNSHolding(s) in Company
7th May 202012:00 pmRNSForm 8.5 (EPT/RI) - Low & Bonar PLC
7th May 202010:37 amRNSHolding(s) in Company
7th May 202010:17 amRNSCourt approval of scheme
7th May 20209:13 amRNSForm 8.3 - Low & Bonar plc
7th May 20208:36 amRNSForm 8.3 - Low & Bonar PLC
6th May 20205:52 pmRNSForm 8.3 - LOW & BONAR PLC
6th May 20205:41 pmRNSHolding(s) in Company
6th May 20203:17 pmPRNForm 8.3 - Low & Bonar plc
6th May 202010:32 amRNSForm 8.3 - Low & Bonar PLC
5th May 20205:30 pmRNSLow & Bonar
5th May 20204:50 pmRNSHolding(s) in Company
5th May 20203:19 pmPRNForm 8.3 - Low & Bonar plc
5th May 20209:18 amRNSForm 8.3 - Low & Bonar PLC
5th May 20208:15 amBUSForm 8.5 (EPT/NON-RI) - LOW & BONAR PLC
4th May 202012:30 pmRNSIntended cancellation of preference shares
4th May 202012:00 pmRNSForm 8.5 (EPT/RI) - Low & Bonar PLC
4th May 202010:17 amRNSForm 8.3 - Low & Bonar PLC
4th May 20209:54 amRNSForm 8.3 - Low & Bonar plc
4th May 20209:30 amBUSFORM 8.5 (EPT/NON-RI) - LOW & BONAR PLC
1st May 20202:55 pmEQSForm 8.3 - Tibra Trading Europe Limited: Low & Bonar PLC
1st May 202010:16 amBUSForm 8.5 (EPT/NON-RI) - Low & Bonar plc
1st May 202010:11 amRNSForm 8.3 - Low & Bonar PLC
30th Apr 20202:55 pmEQSForm 8.3 - Tibra Trading Europe Limited: Low & Bonar PLC
30th Apr 202011:05 amRNSHolding(s) in Company
30th Apr 202010:36 amRNSForm 8.3 - Low & Bonar PLC
30th Apr 202010:06 amBUSFORM 8.5 (EPT/NON-RI) - LOW & BONAR PLC
30th Apr 202010:03 amRNSForm 8.3 - Low & Bonar PLC
30th Apr 20209:08 amRNSTotal Voting Rights
30th Apr 20209:05 amRNSHolding(s) in Company
29th Apr 20203:51 pmRNSDisclosure of Rights Attached To Equity Shares
29th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Low & Bonar PLC
29th Apr 202010:18 amRNSForm 8.3 - LOW & BONAR PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.